Onconetix Announces Reverse Stock Split
Onconetix's board approved a one-for-ten reverse stock split effective 12:01 a.m. ET on November 6, 2026, with the stock continuing to trade on Nasdaq under ONCO. Shares outstanding drop from roughly 5.89 million to about 588,677, with cash paid in lieu of fractional shares; authorized shares remain at 250 million.
Key figures
- Effective date
- 2026-11-06
- Authorized shares
- 250000000
- Reverse split ratio
- 1-for-10
- Shares outstanding after
- 588677
- Shares outstanding before
- 5886774
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.